Related Experiment Video
Updated: May 18, 2026
06:07
Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model
Published on: June 23, 2023
Mouse models of Parkinson's disease associated with mitochondrial dysfunction
Alicia M Pickrell1, Milena Pinto, Carlos T Moraes
1Neuroscience Graduate Program, University of Miami, Miller School of Medicine, Miami, FL 33136, USA.
Molecular and Cellular Neurosciences
|September 8, 2012
Summary
Parkinson's disease (PD) research highlights mitochondrial dysfunction. Mouse models with genetic defects offer insights into PD pathogenesis and therapeutic testing for neurodegenerative diseases.
Area of Science:
- Neuroscience
- Genetics
- Mitochondrial Biology
Background:
- Parkinson's disease (PD) pathogenesis remains incompletely understood despite extensive research.
- Genetic studies in rare familial PD cases implicate mitochondrial dysfunction.
- Mitochondrial dysfunction is increasingly recognized as a key factor in neurodegeneration.
Purpose of the Study:
- To review the characteristics of mouse models relevant to Parkinson's disease.
- To explore how these models aid in understanding PD.
- To assess their utility in preclinical therapeutic testing.
Main Methods:
- Review of existing literature on PD mouse models.
- Analysis of models with genetic alterations affecting mitochondrial function.
- Discussion of phenotypic outcomes and relevance to PD.
Main Results:
- Genetic mouse models with affected mitochondrial genes provide valuable insights into PD.
- These models recapitulate aspects of PD pathology, aiding mechanistic studies.
- They serve as crucial platforms for evaluating potential PD treatments.
Conclusions:
- Mouse models are indispensable tools for advancing Parkinson's disease research.
- Targeting mitochondrial dysfunction is a promising therapeutic strategy for PD.
- Further characterization of these models will accelerate the development of effective PD therapies.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...